ASXL1 truncating variants in BOS and myeloid leukemia drive shared disruption of Wnt-signaling pathways but have differential isoform usage of RUNX3.
| Autor: | Lin, Isabella1,2,3 (AUTHOR), Awamleh, Zain4 (AUTHOR), Sinvhal, Mili1,2,3 (AUTHOR), Wan, Andrew1,2,3 (AUTHOR), Bondhus, Leroy1,2,3 (AUTHOR), Wei, Angela1,2,3,4 (AUTHOR), Russell, Bianca E.3,5 (AUTHOR), Weksberg, Rosanna4,6,7 (AUTHOR), Arboleda, Valerie A.1,2,3,8,9,10 (AUTHOR) varboleda@mednet.ucla.edu |
|---|---|
| Zdroj: | BMC Medical Genomics. 11/29/2024, Vol. 17 Issue 1, p1-20. 20p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|